36
Participants
Start Date
June 23, 2025
Primary Completion Date
March 31, 2027
Study Completion Date
June 30, 2027
CAR-T cells targeting CD19 and CD22
"Using the 3+3 design, the following dose levels will be assessed:~Dose level 1: 0.5x10e6 CAR-transduced T cells/kg; Dose level 2: 1x10e6 CAR-transduced T cells/kg; Dose level 3: 2x10e6 CAR-transduced T cells/kg; Dose level 0: 0.25x10e6 CAR-transduced T cells/kg"
RECRUITING
University Hospital , Department of Internal Medicine II, Tübingen
NOT_YET_RECRUITING
University Hospital, Clinic for Pediatric Medicine, Tübingen
University Hospital Tuebingen
OTHER